SIGA Technologies, Inc. is a commercial-stage pharmaceutical company based in New York, specializing in health security and infectious disease markets. Established in 1995, the company develops antiviral drugs targeting lethal pathogens, including variola virus, which causes smallpox. Its primary product, TPOXX, is an orally administered antiviral treatment specifically designed for human smallpox disease. SIGA is dedicated to creating modern biodefense countermeasures against high-priority viral threats, aiming to prevent and treat diseases such as Ebola, dengue, and Lassa fever. The company primarily generates revenue from the United States market.
Plexus Vaccine engages in the research, development, and design of vaccine products for human and veterinary markets.
Hypernix Technologies
Acquisition in 2000
Hypernix Technologies, Ltd. is an Internet software company focused on developing and launching a freeware product designed for multilateral, real-time communication among users accessing specific URLs on the web. The company has introduced an integrated communication platform called Gooey, which supports the creation of virtual communities through chat and multimedia applications. In addition to the product, Hypernix Technologies is committed to developing a home page and web portal that enhances these communication services. The company plans to market and distribute the product, provide support, and sell advertising space on its platform and website. Furthermore, it intends to sell franchises to other websites, as well as collect and sell data to publishers and data buyers. Hypernix Technologies aims to engage in various aspects of e-commerce and explore additional Internet projects related to its offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.